ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,921,400 | -54.6% | 623,434 | -22.1% | 0.08% | -63.4% |
| Q3 2022 | $8,640,000 | -5.3% | 800,000 | 0.0% | 0.23% | +16.4% |
| Q2 2022 | $9,120,000 | +25.1% | 800,000 | 0.0% | 0.20% | +28.3% |
| Q1 2022 | $7,288,000 | -38.9% | 800,000 | 0.0% | 0.15% | -17.4% |
| Q4 2021 | $11,936,000 | -41.9% | 800,000 | 0.0% | 0.18% | -31.6% |
| Q3 2021 | $20,560,000 | -1.5% | 800,000 | 0.0% | 0.27% | +25.1% |
| Q2 2021 | $20,864,000 | -26.1% | 800,000 | 0.0% | 0.22% | -22.9% |
| Q1 2021 | $28,240,000 | +39.9% | 800,000 | 0.0% | 0.28% | +73.3% |
| Q4 2020 | $20,192,000 | -33.1% | 800,000 | 0.0% | 0.16% | -29.7% |
| Q3 2020 | $30,168,000 | -11.9% | 800,000 | 0.0% | 0.23% | -26.8% |
| Q2 2020 | $34,256,000 | – | 800,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |